-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QG+48ZZfnwUOBgZuK7sJinLDBWi3CPcA0qUm/GRfxAhelNfZlhXmuXLbNMpY5hsB 6T4D+8xMmTI0LFQGGpuVPA== 0001144204-07-008127.txt : 20070214 0001144204-07-008127.hdr.sgml : 20070214 20070214161250 ACCESSION NUMBER: 0001144204-07-008127 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070214 DATE AS OF CHANGE: 20070214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: HANSEN MEDICAL INC CENTRAL INDEX KEY: 0001276591 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-82535 FILM NUMBER: 07620517 BUSINESS ADDRESS: STREET 1: 380 NORTH BERNARDO AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650 404 5800 MAIL ADDRESS: STREET 1: 380 NORTH BERNARDO AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Thomas Weisel Partners Group, Inc. CENTRAL INDEX KEY: 0001340354 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] IRS NUMBER: 203550472 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ONE MONTGOMERY STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-364-2500 MAIL ADDRESS: STREET 1: ONE MONTGOMERY STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94104 SC 13G 1 v065931_sc13.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Hansen Medical Inc. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 411307101 (CUSIP Number) December 31, 2006 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |_| Rule 13d-1(b) |_| Rule 13d-1(c) |X| Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No.: 411307101 1) Names of Reporting Persons. I.R.S. Identification Nos. of Above Persons (entities only) Thomas Weisel Partners Group, Inc. - -------------------------------------------------------------------------------- 2) Check the Appropriate Box if a Member of a Group (a) |_| (See Instructions) (b) |_| - -------------------------------------------------------------------------------- 3) SEC Use Only - -------------------------------------------------------------------------------- 4) Citizenship or Place of Organization Delaware (USA) - -------------------------------------------------------------------------------- Number of Shares 5) Sole Voting Power: 1,765,055 Beneficially ---------------------------------------------------- Owned by Each 6) Shared Voting Power Reporting ---------------------------------------------------- Person With 7) Sole Dispositive Power: 1,765,055 ---------------------------------------------------- 8) Shared Dispositive Power - -------------------------------------------------------------------------------- 9) Aggregate Amount Beneficially Owned by Each Reporting Person: 1,765,055(1) - -------------------------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) |_| - -------------------------------------------------------------------------------- 11) Percent of Class Represented by Amount in Item 9: 8.2% - -------------------------------------------------------------------------------- 12) Type of Reporting Person (See Instructions): CO ITEM 1. (A) NAME OF ISSUER: Hansen Medical Inc. (B) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICE 380 North Benardo Avenue Mountain View, CA 94043 ITEM 2. (A) NAME OF PERSONS FILING: Thomas Weisel Partners Group, Inc. (B) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR IF NONE, RESIDENCE One Montgomery Street San Francisco, CA 94104 (C) CITIZENSHIP: Delaware (USA) (D) TITLE OF CLASS OF SECURITIES: Common Stock (E) CUSIP NUMBER: 411307101 ITEM 3. Not Applicable If this statement is filed pursuant to rule 240.13d- 1(b), or 240.13d-2(b) or (c), check whether the person filing is a: (a) ___ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) ___ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) ___ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) ___ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) ___ An investment adviser in accordance with 240.13d- 1(b)(1)(ii)(E). (f) ___ An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F). (g) ___ A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G) (h) ___ A savings association as defined in section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). (i) ___ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). (j) ___ Group, in accordance with section 240.13d-1(b)(1)(ii)(J). ITEM 4. OWNERSHIP. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 1,765,055 (b) Percent of class: 8.2% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 1,765,055 (ii) Shared power to vote or to direct the vote: (iii) Sole power to dispose or to direct the disposition of: 1,765,055 (iv) Shared power to dispose or to direct the disposition of: ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following /___/. Not Applicable ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not Applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Thomas Weisel Partners Group, Inc. is the sole managing member of Thomas Weisel Capital Management LLC, the managing member of Thomas Weisel Healthcare Venture Partners LLC, which is General Partner of Thomas Weisel Healthcare Venture Partners, L.P. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not Applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not Applicable ITEM 10. CERTIFICATION. By signing below we certify that, to the best of our knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Dated: February 14, 2007 By: /s/ Mark Fisher ---------------------------- Name: Mark Fisher Title: General Counsel and Secretary (1) Thomas Weisel Partners Group, Inc. exercises discretionary authority as ultimate parent over the investments of Thomas Weisel Healthcare Venture Partners, L.P., Thomas Weisel Partners Group, Inc. disclaims beneficial ownership of all shares except 8,825 shares which ownership corresponds to Thomas Weisel Partners Group, Inc.'s invested capital in Thomas Weisel Healthcare Venture Partners, L.P. -----END PRIVACY-ENHANCED MESSAGE-----